The US Senate voted on Wednesday to confirm Dr. Rachel Levine as assistant secretary for health in the Department of Health and Human Services.
With a vote of 52-48, President Biden’s nominee Levine, who previously served as Pennsylvania’s secretary of health, became the first transgender federal official to receive confirmation by the chamber.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
Breitbart reports: Senate Majority Leader Chuck Schumer (D-NY) insisted in a statement that Levine’s confirmation “represents another important milestone for the American LGBTQ community.”
“As transgender Americans suffer higher rates of abuse, homelessness and depression than almost every other group, it’s important to have national figures like Dr. Levine who by virtue of being in the public spotlight will help break down barriers of ignorance and fear,” Schumer said.
Upon announcing the nomination in January, Biden said Levine “will bring the steady leadership and essential expertise we need to get people through this pandemic — no matter their zip code, race, religion, sexual orientation, gender identity, or disability — and meet the public health needs of our country in this critical moment and beyond.”
Levine, who has faced extreme opposition from Senate Republicans, was confronted by Sen. Rand Paul (R-KY) during the confirmation hearings and pressed on the danger to children of “transgender” therapies.
Critics also slammed Levine for touting and publicizing a January 2020 study that declared puberty-blocking drugs to be beneficial for young children and recommended “accelerating” cross-sex hormones for homeless teens who are suffering from gender dysphoria and estranged from their parents.
Latest posts by Niamh Harris (see all)
- Top Netanyahu Aide Says Israel Will Create ‘Security Envelope’ To Enclose Gaza - December 4, 2023
- White House Says Money For Ukraine Is ‘Desperately’ Needed - December 4, 2023
- Pentagon Extremism Report: Dozens Of US Soldiers Want To Overthrow US Government - December 4, 2023